Skip to Main Content
Legislation Search

H.R. 1671: Justice for Vaccine Injured Veterans Act of 2025

The Justice for Vaccine Injured Veterans Act of 2025 is a proposed piece of legislation aimed at modifying existing laws related to veteran health benefits. Here’s a breakdown of its key provisions:

Objective of the Bill

The primary aim of the bill is to provide a legal presumption that certain diseases associated with the COVID-19 vaccine are connected to military service. This is specifically for service members who received the vaccine under orders during a defined time frame.

Time Frame Covered

The time period covered by this legislation is from August 24, 2021, to January 10, 2023. Veterans who developed specific health conditions during this period after vaccination would be considered to have these conditions related to their military service, even if there is no direct evidence linking the condition to their time in service.

Diseases Covered

The bill identifies several specific medical conditions that would be presumed to be service-connected, including:

  • Myocarditis
  • Pericarditis
  • Thrombosis with thrombocytopenia syndrome
  • Guillain-Barre Syndrome
  • Any other disease as determined by the Secretary of Veterans Affairs that has a positive association with the COVID-19 vaccine.

Reporting Requirements

The Secretary of Veterans Affairs will be required to report regularly to Congress regarding:

  • The total number of compensation claims filed related to the diseases associated with the COVID-19 vaccine.
  • The status of these claims, including how many were approved, denied, or still pending.

These reports must be submitted every 60 days for a period of four years following the enactment of the bill.

Public Availability of Reports

All reports generated under this legislation will be made publicly accessible, allowing for transparency regarding the handling of claims related to vaccine injuries.

Definition of COVID-19 Vaccine

The bill defines a COVID-19 vaccine as any vaccine licensed or authorized for emergency use for prevention against the COVID-19 virus under relevant public health laws.

Legislative Process

The bill was introduced in the U.S. House of Representatives and referred to the Committee on Veterans' Affairs, as well as the Committee on Armed Services. Its advancement through Congress will depend on further committee review and voting processes.

Relevant Companies

None found.

This is an AI-generated summary of the bill text. There may be mistakes.

Show More

Sponsors

9 bill sponsors

Actions

3 actions

Date Action
Mar. 27, 2025 Referred to the Subcommittee on Disability Assistance and Memorial Affairs.
Feb. 27, 2025 Introduced in House
Feb. 27, 2025 Referred to the Committee on Veterans' Affairs, and in addition to the Committee on Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Corporate Lobbying

0 companies lobbying

None found.

* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.

Potentially Relevant Congressional Stock Trades

No relevant congressional stock trades found.